Skip to main content
. 2018 Sep 28;104(3):599–608. doi: 10.3324/haematol.2018.195669

Table 2.

Evaluation of zero/negligible inhibitor risk prediction with and without proteome scanning.

graphic file with name 104599.tab2.jpg